KIMBERLY MYERS: Open Payments
NPI 1952839961 · GREENDALE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 48 payments from 20 companies in 2025. Trend: 2023 $587 · 2024 $937 · 2025 $874
Food & beverage: $838Education: $36
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $202 |
| Vanda Pharmaceuticals Inc. | 11 | $152 |
| Novo Nordisk Inc | 4 | $71 |
| PFIZER INC. | 4 | $63 |
| Alkermes, Inc. | 2 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| ABIOMED | 1 | $31 |
| Exact Sciences Corporation | 1 | $28 |
| Medtronic, Inc. | 1 | $22 |
Products named: VRAYLAR, FANAPT, ARISTADA, REXULTI, Ozempic, NURTEC ODT, UBRELVY, Kerendia.
Industry payments across IN — which companies pay providers there.
